Literature DB >> 3608735

Fusidic acid-induced hyperbilirubinemia.

K P Kutty, I V Nath, K R Kothandaraman, J A Barrowman, P G Perkins, M U Ra, S N Huang.   

Abstract

A 72-year old man developed jaundice while on fusidic acid therapy for suspected osteomyelitis. Hyperbilirubinemia was predominantly of the conjugated variety and elevation in liver enzymes was mild and transient. Although serum bilirubin fell rapidly after fusidic acid was stopped, complete resolution of the hyperbilirubinemia took nearly a month. Other possible causes of jaundice were excluded. Light microscopy of a needle liver biopsy showed focal hepatocyte feathery degeneration, intracellular bile retention, and canalicular bile plugging, most prominent in perivenous regions. Electron microscopy revealed varying degrees of canalicular dilatation, loss of microvilli, and disruption of the canalicular membrane with vesicular bleb formation as well as canalicular bile plugs. Widening of the pericanalicular ectoplasmic zone with accumulation of cytoskeletal filaments was also noted. These findings are similar to those reported in experimental cholestasis induced by bile acids. Possible mechanisms of jaundice caused by fusidic acid are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3608735     DOI: 10.1007/bf01296717

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Microfilament dysfunction as a possible cause of intrahepatic cholestasis.

Authors:  M J Phillips; M Oda; E Mak; M M Fisher; K N Jeejeebhoy
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

2.  METABOLIC EFFECTS OF THE STEROID ANTIBIOTIC FUSIDIC ACID.

Authors:  V WYNN
Journal:  Br Med J       Date:  1965-05-29

3.  Treatment of staphylococcal infections with "fucidin".

Authors:  R B CROSBIE
Journal:  Br Med J       Date:  1963-03-23

4.  Antistaphylococcal activity of fucidin.

Authors:  G TAYLOR; K BLOOR
Journal:  Lancet       Date:  1962-05-05       Impact factor: 79.321

5.  Additives to intravenous fluids.

Authors:  R L Parsons; J P Beavis; G M Paddock; J A David; J R Trounce
Journal:  Br Med J       Date:  1976-11-20

6.  Fusidate sodium in treatment of surgical infections.

Authors:  P Dineen
Journal:  Arch Surg       Date:  1968-02

7.  Scanning electron microscopy of the rat liver. Studies of the effect of taurolithocholate and other models of cholestasis.

Authors:  T J Layden; J L Boyer
Journal:  Gastroenterology       Date:  1975-09       Impact factor: 22.682

8.  Effects of taurodihydrofusidate, a bile salt analogue, on bile formation and biliary lipid secretion in the rhesus monkey.

Authors:  M Beaudoin; M C Carey; D M Small
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3beta-hydroxy-5-cholenoic, cholic, and dehydrocholic acids.

Authors:  K Miyai; A L Richardson; W Mayr; N B Javitt
Journal:  Lab Invest       Date:  1977-03       Impact factor: 5.662

10.  Micellar properties of sodium fusidate, a steroid antibiotic structurally resembling the bile salts.

Authors:  M C Carey; D M Small
Journal:  J Lipid Res       Date:  1971-09       Impact factor: 5.922

View more
  2 in total

1.  Fusidic acid induced jaundice.

Authors:  M Haddad; S Shabat; A Koren; E Stelman; A Zelikovski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

2.  Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

Authors:  J D Peter; F Jehl; T Pottecher; J P Dupeyron; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.